Enrico Patrucco

8PUBLICATIONS
78CO-AUTHORS
Molecular targetsOther biological sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Mar 12, 2025
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD.

Fernando C Baltanás, Maximilian Kramer-Drauberg, Rósula García-Navas

|Aug 30, 2024
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.

Marie-Julie Nokin, Alessia Mira, Enrico Patrucco

|Jun 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.

Cristina Mastini, Marco Campisi, Enrico Patrucco

|Jan 29, 2022
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.

Biagio Ricciuti, Jieun Son, Jeffrey J Okoro

|Oct 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.

Elif Karaca Atabay, Carmen Mecca, Qi Wang

Pageof 2

Frequent Collaborators

6 joint publications

Chiara Ambrogio

4 joint publications

Roberto Chiarle

4 joint publications

Claudia Voena

3 joint publications

Taek-Chin Cheong